|1.||Swarnakar, Snehasikta: 3 articles (05/2008 - 07/2007)|
|2.||Kupriyanova, Tatyana A: 2 articles (10/2014 - 09/2011)|
|3.||Quigley, James P: 2 articles (10/2014 - 09/2011)|
|4.||Deryugina, Elena I: 2 articles (10/2014 - 09/2011)|
|5.||Zajac, Ewa: 2 articles (10/2014 - 09/2011)|
|6.||Jurisic, Vladimir: 2 articles (01/2014 - 04/2010)|
|7.||Gopcevic, Kristina: 2 articles (01/2014 - 04/2010)|
|8.||Konjevic, Gordana: 2 articles (01/2014 - 04/2010)|
|9.||Aletras, Alexios J: 2 articles (08/2009 - 10/2005)|
|10.||Sharma, Anamika Vivek: 2 articles (05/2008 - 08/2007)|
|1.||Wounds and Injuries (Trauma)
09/01/2015 - "Overexpression of Ang-1 resulted in greatly improved re-epithelialization, neovascularization, and EPC recruitment in diabetic BM-transplanted wounds at day 7. Ang-1 treatment resulted in increased serum levels of proMMP-9 and SCF but had no effect on vascular endothelial growth factor levels. "
10/01/2014 - "Whereas host MMP-9 competence was required for full angiogenic potential of both normal and tumor-associated leukocytes, direct comparisons of neutrophils versus macrophages and TANs versus TAMs demonstrated that macrophages and TAMs secrete 40- to 50-fold less proMMP-9 than the same numbers of neutrophils or TANs. "
10/01/2014 - "Accumulated evidence, however, indicates that tumor-associated neutrophils (TANs) are also critically important for proMMP-9 delivery, especially at early stages of tumor development. "
01/01/2014 - "ProMMP-9 and aMMP-9 activity in tumor tissue shows a positive association with tumor size. "
09/01/2011 - "Specific roles of inflammatory neutrophils and their distinct proMMP-9 in the coordinate regulation of tumor angiogenesis and tumor cell dissemination, however, have not been addressed. "
12/01/2008 - "By zymography, we observed an increased proMMP-9 expression in both metastasized liver and spleen samples from tumor bearing rats. "
05/01/2007 - "Our results therefore suggested that during inflammation degranulation of mast cells results in a reduction of the proMMP-9-TIMP-1 complex levels, together with a fall in the amount of free proMMP-9."
01/01/2005 - "Interestingly, proMMP-9 values in general correlated with CRP, a systemic marker of inflammation. "
11/01/2012 - "Hypoxia and inflammation are suggested to play an important role in activating proMMP-9, presumably via Hsp90."
08/01/2011 - "Present data suggest that the lipid moiety of HZ alters the MMP/TIMP balances and promotes the proteolytic activation of proMMP-9 in HMEC-1, thereby enhancing total gelatinolytic activity, cell activation and inflammation. "
06/01/2004 - "To confirm the etiological association with inflammation and to explore time course of release of proMMP-9 under conditions of a local inflammatory reaction, the authors estimated proMMP-9 in pleural fluids of patients undergoing therapeutic talc pleurodesis (n = 20) and explorative thoracoscopy (n = 4), before, and at different time intervals after the intervention. "
|4.||Breast Neoplasms (Breast Cancer)
04/01/1997 - "In conclusion, proMMP-9 production was the main cause of increased MMP-9 activity during the early phase, while both production and activation increased in the late phase of breast cancer."
04/01/1997 - "During the early phase of breast cancer (DCIS and T1 stage) progression, only production of proMMP-9 increased. "
05/18/2006 - "We conclude that MMP-7 over-expression correlates with breast cancer in vitro invasiveness and that MMP-7 may promote invasion by increasing the secretion and activation of proMMP-2 and proMMP-9."
09/01/2006 - "ProMMP-2, activated MMP-2, proMMP-9 and activated MMP-9 levels were significantly higher in tumor tissues than that of corresponding paired adjacent normal tissue of 60 breast cancer patients (p<0.01). "
04/15/2010 - "In this study, we examined serum activity of proMMP-2 and proMMP-9 in relation to TNM stage, tumor size, lymph node involvement, grade of differentiation of tumors, as well as steroid and Her2/neu receptor status in breast cancer patients. "
02/01/2000 - "This study suggests that a specific regional induction of pro-matrix metalloproteinase 9 occurs in the cervical area before labor and may play a role in "programming" this area for subsequent rupture after activation during labor."
02/01/2000 - "Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture."
06/01/2007 - "Secretion of proMMP-2 and proMMP-9 mainly in the CHD, presence of active forms associated to the tissue and minor changes in TIMPs secretion could favor ECM degradation and explain the weakening and thinning associated with the pathological rupture of chorioamniotic membranes."
02/01/2000 - "After delivery both pro-matrix metalloproteinase 2 and 9 activities were elevated, whereas pro-matrix metalloproteinase 9 protein activity showed no regional difference between the rupture site and midzone (23.47 +/- 4.5 vs 25. "
03/01/2015 - "In conclusion, the current validated gelatin zymography detected a gradient proMMP-9 expression on the non-retaining placenta of cows in reverse to the proximity to the umbilical insertion point, and a gradient proMMP-2 expression on a section of the umbilical cord in reverse to the proximity to the rupture site, suggesting roles played by gelatinases in normal discharge of the placenta at term. "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||Tissue Inhibitor of Metalloproteinase-1
|7.||Matrix Metalloproteinase 1 (Interstitial Collagenase)
|9.||erbB-2 Receptor (Receptor, erbB 2)
|2.||Heterologous Transplantation (Xenotransplantation)